Inhaled Nitric Oxide Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32
                     Global Inhaled Nitric 
Oxide Market Research 
and Forecast Report 
2024-2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
A cc o r d i ng  t o  t h e  l a t e s t  r e p o r t  b y  I M A R C  Gr o u p ,  t i t l e d  " I n h a l e d  N i t r ic  O x i d e  Ma r k e t :  
G l o b a l  I n d u s t r y  T r e n d s ,  S h a r e ,  S i z e ,  Gr o w th ,  O p p o r t u n i t y  a n d  F o r e c as t  2 0 2 4 -
20 3 2 , "  t h e  g l o b a l  i nh a l e d  n i t r i c  o x i d e  ma r k e t  s i z e  re a c h e d  U S $  94 3 . 7  M i l l i o n  i n  2 0 2 3 .
Fac tors  A f fec t ing  the  Growth  o f  t he  Inha led  N i t r ic  Ox ide  Indust ry :
Report Expanding  C l in ica l  Appl ica t ions  and Evolv ing  Ev idence :On e  o f  t h e  p r i m a r y  f a c t o r s  p r o pe l l i n g  t he  g r o w th  o f  t h e  i nh a l e d  n i t r i c  o x i d e  i n d u s t r y  i s  
t he  e x p a nd i n g  c l i n i c a l  a p p l i ca t i o n s  a n d  ev o l v i n g  e v i d e nc e .  H i s t o r i c a l l y  k n o w n  f o r  i t s  
Highlight and u t i l i t y  i n  t h e  t r e a tm e n t  o f  n e o n a t a l  h yp o x i c  r e s p i ra t o r y  f a i l u r e ,  i nh a l e d  n i t r i c  o x i d e  h as  se e n  i n c re a s e d  a d o p t i o n  i n  t he  m a na g e me n t  o f  v a r i o us  p u l m o n a r y  a n d  c a r d i ov a s c u l a r  
co n d i t i o ns .  
Description T h i s  e x p an s i o n  i s  s u p po r t e d  b y  a  g r ow i n g  b o d y  o f  e v i d e n c e  d e mo n s t r a t i n g  t h e  e f f i c a cy  
o f  i N O i n  a dd r e s s i ng  c on d i t i o n s  s u c h  a s  p e r s i s t en t  pu l m o n a r y  h yp e r t en s i o n  o f  t h e  
ne w b o r n  ( P P H N ) ,  a c u te  r e s p i ra t o r y  d i s t r e ss  s y n d ro m e  ( A R D S ) ,  an d  pu l m o n a ry  
hy p e r t en s i o n .  Mo r e o ve r ,  r e s e a r c h  i s  u nd e r w ay  t o  ex p l o r e  i t s  p o te n t i a l  i n  c o n d i t i o n s  l i k e  
ch r o n i c  o b s t r u c t i v e  p u l m o na r y  d i s ea s e  ( C O P D )  a n d  p u l mo n a r y  f i b r o s i s .  T h e  a v a i l a b i l i t y  
o f  r o b u s t  c l i n i c a l  d a ta  c o n t i n u es  t o  d r i v e  t h e  u t i l i z a t i o n  o f  i N O  a c ro s s  a  b r o a d e r  
sp e c t r um  o f  m e d i ca l  s p e c i a l t i e s ,  t h e r e by  c o n t r i b u t i n g  t o  t h e  i n d u s t r y ' s  o ve r a l l  g ro w t h .
Technologica l  Advancements  and Cost -Ef fect iveness:
Ano t he r  c r uc ia l  f ac t o r  i n f l uenc in g  t h e  iNO  indu s t r y ' s  g r ow t h  i s  t he  co n t i nuo us  
t ech no log i ca l  a dvanc em e n t s  and  t he  pu r s u i t  o f  cos t - e f f e c t i v eness .  As  a dvan cem e n t s  
i n  d r ug  de l i ve r y  sy s t em s  a nd  m ed ica l  d ev i ce s  con t i nu e  t o  evo l ve ,  t he  adm in i s t r a t i on  
o f  i n ha led  n i t r i c  ox i de  bec om e s  m or e  r e f i n ed  an d  acces s ib le .  I nno va t i on s  such  as  
Report i n t e g r a t e d  de l i ve r y  sys t em s  a nd  p r e c i se  d ose  m on i t o r i ng  con t r i bu t e  t o  t h e  i m pr o ved  
sa f e t y  an d  e f f i cacy  o f  iNO  t he r a py ,  e xpand ing  i t s  app l i c ab i l i t y  ac r os s  d i ve r se  
c l i n i ca l  se t t i ngs .  
Highlight and Fur t he r m or e ,  ong o ing  e f f o r t s  t o  o p t im iz e  m an u f ac t u r i n g  p r o cesse s ,  enh anc e  p r od uc t  
f o r m u la t io ns ,  and  s t r eam l ine  supp l y  ch a ins  con t r i bu t e  t o  t h e  c os t - e f f e c t i ven ess  o f  
Description iNO  t h e r apy .  T hese  adva ncem en t s  i n  t ech no logy  an d  co s t  m anag em e n t  n o t  on l y  d r i v e  m a r ke t  exp ans io n  bu t  a ls o  s t r eng t hen  t he  va lue  p r opo s i t i on  o f  iNO  in  c l in i ca l  
p r ac t i ce ,  pos i t i on in g  i t  as  a  v iab le  t r ea t m en t  op t i on  i n  va r io us  h ea l t hc a r e  se t t i ngs .
Regulatory  Landscape and Reimbursement  Pol ic ies:
The  r e gu la t o r y  l and scape  an d  r e im bur sem en t  po l i c i es  f o r m  a  c r i t i c a l  f ac t o r  sha p ing  
t he  g r ow t h  t r a jec t o r y  o f  t h e  iNO  indu s t r y .  As  i nha le d  n i t r i c  ox ide  t he r apy  b eco m es  
i nc r eas ing l y  i n t e g r a t e d  i n t o  s t and a r d  t r ea t m en t  p r o t o co l s ,  r egu la t o r y  ag enc ie s  p lay  
a  p i vo t a l  r o le  i n  es t ab l i sh in g  qua l i t y  s t and a r ds ,  sa f e t y  r egu l a t i ons ,  and  app r ova l  
p r oc esses  f o r  iNO - r e la t ed  p r odu c t s ,  e nsu r ing  pa t i en t  sa f e t y  a nd  e f f i ca cy .
Concurren t l y ,  t he  a l ignmen t  o f  re imbursement  po l i c ies  w i th  the  evo lv ing  
c l i n ica l  ev idence  and  p rac t ice  gu ide l ines  is  essen t ia l  i n  fos te r ing  the  
w idespread  adop t ion  o f  iNO therapy .  The  es tab l ishment  o f  re imbursement  
s t ruc tu res  tha t  re f lec t  t he  va lue  o f  iNO in  manag ing  d i f f e ren t  d isease  s ta tes ,  
coup led  w i th  the  inc lus ion  o f  iNO the rapy  in  es tab l ished  hea l thcare  
re imbursements ,  augmen ts  i t s  access ib i l i t y  and  u t i l i za t ion .
Report 
Request  for  a  PDF sample  o f  th is  repor t :  
Highlight and h t tps : / /www. imarcgroup .com/ inha led -n i t r i c -ox ide -marke t / reques tsamp le
Description
Report Description
Global  Inhaled Nitr ic Oxide Market Trends:
The g loba l  inhaled n i t r i c  ox ide market  is  expected to wi tness s ign i f icant  growth.  Fac tors  such as 
expanding c l in ica l  appl icat ions  in  pulmonary and card iovascular  cond i t ions ,  technolog ical  advancements 
enhancing prec is ion and cost -e f fec t iveness ,  and favorable  regu latory  and re imbursement  landscapes 
are  pro jected to  dr ive  market  expansion.  
Fur thermore,  increas ing research and development  ac t iv i t ies ,  coupled w i th r is ing awareness o f  the 
therapeut ic  benef i ts  of  inha led n i t r ic  ox ide,  are ant ic ipated to fur ther  propel  market  t rends.  The market  
is  l i ke ly  to  see he ightened adopt ion in  d iverse medical  spec ia l t ies  and enhanced access ib i l i ty ,  
pos i t ion ing inhaled n i t r ic  ox ide as a va luable t reatment  opt ion in  the g lobal  hea l thcare landscape.
View Report  TOC, Figures and Tables :  ht tps: / /www.imarcgroup.com/inhaled-nit r ic-oxide-market
Breakup by Application:
• Neonatal Respiratory Treatment
• Chronic Obstruct ive Pulmonary Disease (COPD)
• Acute Respiratory Distress Syndrome (ARDS)
• Others
Report 
Breakup by Region:
Segmentation • North America
• Asia-Pacifi c
• Europe
• Lat in Amer ica
• Middle East  and Afr ica
• Air Liquide S.A
• Bellerophon Therapeutics
• Beyond Air Inc.
Competitive • Linde plc
Landscape • Mall inckrodt plc
• Merck KGaA
with Key • Novoteris LLC
Players • Nu-Med Plus
• VERO Biotech LLC.
How has the global inhaled nitric oxide market 
performed so far and how will it perform in the coming 
years?
What has been the impact of COVID-19 on the global 
inhaled nitric oxide market?
What are the key regional markets?
Key 
Questions What is the breakup of the market based on the application?
Answered in 
What are the various stages in the value chain of the 
the Report industry?
What are the key driving factors and challenges in the 
industry?
What is the structure of the global inhaled nitric oxide 
market and who are the key players?
What is the degree of competition in the industry?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
Table of         2 . 4 . 1     B o t t o m - U p  A p p r o a c h        2 . 4 . 2     T o p - D o w n  A p p r o a c h
    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
Contents     4 . 1     O v e r v i e w    4 . 2     K e y  I n d u s t r y  T r e n d s5     G l o b a l  I n h a l e d  N i t r i c  O x i d e  M a r k e t
    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  F o r e c a s t
6      M a r k e t  B r e a k u p  b y  A p p l i c a t i o n
    6 . 1     N e o n a t a l  R e s p i r a t o r y  T r e a t m e n t
        6 . 1 . 1  M a r k e t  T r e n d s
        6 . 1 . 2  M a r k e t  F o r e c a s t
    6 . 2     C h r o n i c  O b s t r u c t i v e  P u l m o n a r y  D i s e a s e  ( C O P D )
        6 . 2 . 1  M a r k e t  T r e n d s
        6 . 2 . 2  M a r k e t  F o r e c a s t
    6 . 3     A c u t e  R e s p i r a t o r y  D i s t r e s s  S y n d r o m e  ( A R D S )
        6 . 3 . 1  M a r k e t  T r e n d s
        6 . 3 . 2  M a r k e t  F o r e c a s t
       
    6 . 4     O t h e r s
        6 . 4 . 1  M a r k e t  T r e n d s
        6 . 4 . 2  M a r k e t  F o r e c a s t
7    M a r k e t  B r e a k u p  b y  R e g i o n
    7 . 1     N o r t h  A m e r i c a
        7 . 1 . 1  U n i t e d  S t a t e s
           7 . 1 . 1 . 1  M a r k e t  T r e n d s
           7 . 1 . 1 . 2  M a r k e t  F o r e c a s t
        7 . 1 . 2  C a n a d a
           7 . 1 . 2 . 1  M a r k e t  T r e n d s
           7 . 1 . 2 . 2  M a r k e t  F o r e c a s t
    7 . 2     A s i a - P a c i f i c
Table of         7 . 2 . 1  C h i n a
           7 . 2 . 1 . 1  M a r k e t  T r e n d s
           7 . 2 . 1 . 2  M a r k e t  F o r e c a s t
Contents         7 . 2 . 2  J a p a n           7 . 2 . 2 . 1  M a r k e t  T r e n d s
           7 . 2 . 2 . 2  M a r k e t  F o r e c a s t
        7 . 2 . 3  I n d i a
           7 . 2 . 3 . 1  M a r k e t  T r e n d s
           7 . 2 . 3 . 2  M a r k e t  F o r e c a s t
        7 . 2 . 4  S o u t h  K o r e a
           7 . 2 . 4 . 1  M a r k e t  T r e n d s
           7 . 2 . 4 . 2  M a r k e t  F o r e c a s t
        7 . 2 . 5  A u s t r a l i a
           7 . 2 . 5 . 1  M a r k e t  T r e n d s
           7 . 2 . 5 . 2  M a r k e t  F o r e c a s t
        7 . 2 . 6  I n d o n e s i a
           7 . 2 . 6 . 1  M a r k e t  T r e n d s
           7 . 2 . 6 . 2  M a r k e t  F o r e c a s t
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
h t t p s : / / w w w. im a rcg ro u p . co m / in h a led - n i t r i c - ox id e - m a r ke t / t o c
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us: